Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.
Also called NCT04542148
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT04542148
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04542148. Randomized; no masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2025-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Preterm Birth
- Condition
- Pregnancy, High Risk
- Condition
- Diabetes, Gestational
- Intervention (Drug)
- Sliding Scale Insulin
- Intervention (Drug)
- Up-Titration of Home Insulin
- Intervention (Drug)
- Continuous Insulin Infusion
- Intervention (Device)
- Dexcom G6 Professional Continuous Glucose Monitor
- Lead sponsor
- University of Alabama at Birmingham
- Collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Record details
- Record id
cardio:ct-nct04542148- Content hash
d98b247df787c6bc013286755f21cd0de95310f61c9584c672a6c1dad36f140f